Please wait while the formulary information is being retrieved.
VIT 3 (OMEGA-3/DHA/EPA/B12/FOLIC ACID/PYRIDOXINE HCL/PHYTOSTEROLS)
- Vitamin deficiency
- Vitamin deficiency prevention
500 mg-500 mcg-1 mg-12.5 mg capsule
- Dosage information is not available
- altretamine
- cisplatin
- Hexalen
Contraindicated
- None
Severe
Moderate
- Cerebyx
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- ethotoin
- fosphenytoin
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- History of total gastrectomy
- Leber's hereditary optic atrophy
Contraindicated
- None
Severe
Moderate
- Atrophic gastritis
- Hypokalemia
VIT 3 (OMEGA-3/DHA/EPA/B12/FOLIC ACID/PYRIDOXINE HCL/PHYTOSTEROLS)
- Vitamin deficiency
- Vitamin deficiency prevention
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysgeusia
- Dyspepsia
- Eructation
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bronchospastic pulmonary disease
- Concentration difficulty
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
Less Severe
- Abdominal distension
- Abnormal hepatic function tests
- Acute confusion
- Anorexia
- Constipation
- Depression
- Dysgeusia
- Erythema
- Excitement
- Flatulence
- Irritability
- Malaise
- Nausea
- Pruritus of skin
- Skin rash
- Sleep disorder
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Folic Acid
- Severity Level:
A
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Vitamin deficiency | |
| E56.9 | Vitamin deficiency, unspecified |
| 0-9 | A-Z |
|---|---|
| E56.9 | Vitamin deficiency, unspecified |
Formulary Reference Tool